Leo Pharma Asia
| About us | LEO Pharma Asia Pte Ltd is the Asia Regional Office (ARO) for countries in Asia. LEO ARO was established in 1988 and is a subsidiary of LEO Pharma, which was founded in Copenhagen, Denmark, in 1908. LEO Pharma is owned entirely by the LEO Foundation, which is an independent, private institution with the objective to support research within the medical, chemical and pharmaceutical fields. As a foundation, LEO has no external shareholders. This means that all the money earned from the sales of LEO products goes back into more research and development. LEO is thus committed to the long-term research goals necessary to continue the development of LEO as a successful, efficient, responsible and professional research-based company. The LEO Group employs more than 3,200 persons worldwide and has manufacturing facilities in Denmark, France and Ireland. |
|---|---|
| Industry Focus | Bio-technology Products, Drugs & Medications, Pharmaceutical Chemicals |
| Business Type | Manufacturer |
| Products/Services | Cobra Venom Factor, Ribonuclease, Fibrinolytic Enzyme |
| Our Markets | Worldwide |
| No. of Employees | Above 1000 People |
| Annual Sales Range(USD) | Above US$100 Million |
| Year Established | 1988 |
| Certificates | ISO/FDA... |
